Bayer Acquires AskBio to Broaden Innovation Base in Cell and Gene Therapy
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio) announced an agreement under which Bayer will acquire AskBio, a U.S.-headquartered biopharmaceutical company specializing in the research, development and manufacturing of gene therapies across different therapeutic areas.
Duke University Redoubles Efforts to Convert Research Into Social Impact
With a sweeping administrative restructuring and new resources for technology transfer operations, Duke University will be enhancing the ability of faculty and staff to bring their scientific ideas into the marketplace and create new economic opportunities for the region and the nation.
IonQ, Inc., a leader in quantum computing, completed its previously announced business combination with dMY Technology Group, Inc. III, a publicly traded special purpose acquisition company, on September 30, 2021.
Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications.
Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury
Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter injury (WMI) and myelin repair in premature babies, today announced a seed investment from Xontogeny, LLC to advance their lead program through IND-enabling work.
Sparta Biomedical Receives FDA Breakthrough Device Designation for Biomimetic Implant
Sparta Biomedical Inc., a developer of orthopedic solutions, today announced that its SBM-01 Biomimetic Implant has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration.